IEEE/ACM Trans Comput Biol Bioinform. 2018 Nov-Dec;15(6):2039-2052. doi: 10.1109/TCBB.2017.2760827. Epub 2017 Oct 9.
This paper proposes a novel consensus gene selection criteria for partial least squares-based gene microarray analysis. By quantifying the extent of consistency and distinctiveness of the differential gene expressions across different double cross validations (CV) or randomizations in terms of occurrence and randomization p-values, the proposed criteria are able to identify a more comprehensive genes associated with the underlying disease. A Distributed GPU implementation has been proposed to accelerate the gene selection problem and about 8-11 times speed up has been achieved based on the microarray datasets considered. Simulation results using various cancer gene microarray datasets show that the proposed approach is able to achieve highly comparable classification accuracy in comparing with many conventional approaches. Furthermore, enrichment analysis on the selected genes for Diffused Large B Cell Lymphoma (DLBCL) and Prostate Cancer datasets and show that only the proposed approach is able to identify gene lists enriched in different pathways with significant p-values. In contrast, sufficient statistical significance cannot be found for conventional SVM-RFE and the t-test. The reliability in identifying and establishing statistical significance of the gene findings makes the proposed approach an attractive alternative for cancer related researches based on gene expression profiling or other similar data.
本文提出了一种新的基于偏最小二乘的基因芯片分析共识基因选择标准。通过定量不同双交叉验证(CV)或随机化中差异基因表达的一致性和独特性程度,以出现和随机化 p 值表示,所提出的标准能够识别与潜在疾病相关的更全面的基因。已经提出了一种分布式 GPU 实现来加速基因选择问题,并且根据所考虑的微阵列数据集实现了约 8-11 倍的加速。使用各种癌症基因微阵列数据集的仿真结果表明,与许多传统方法相比,所提出的方法能够实现高度可比的分类准确性。此外,对 Diffused Large B Cell Lymphoma (DLBCL) 和 Prostate Cancer 数据集的选定基因进行富集分析,并表明只有所提出的方法能够识别在不同途径中富集且具有显著 p 值的基因列表。相比之下,传统的 SVM-RFE 和 t 检验无法找到足够的统计显著性。所提出的方法在识别和建立基因发现的统计显著性方面的可靠性使得该方法成为基于基因表达谱或其他类似数据的癌症相关研究的一个有吸引力的替代方案。